Bausch + Lomb Corporation
Organization details
- Legal name
- Bausch + Lomb Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3851 — Ophthalmic Goods
- Headquarters city
- Vaughan
- Fiscal year end
- December
- Ticker symbol
- BLCO
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001860742
Board of directors
-
Barbara Trebbi · DirectorSince 2026
-
Brent L. Saunders · Director · Chairman of the Board and CEOSince 2023
- Since 2023
-
Eduardo Alfonso · DirectorSince 2026
-
Eschenbach Andrew C. Von · DirectorSince 2023
-
Gaoxiang Hu · DirectorSince 2023
-
John Paulson · DirectorSince 2023
-
Karen Ling · DirectorSince 2024
-
Laurence E. Paul · DirectorSince 2026
-
Nathalie D. Bernier · DirectorSince 2023
-
Robert J. Chersi · DirectorSince 2026
-
Russel C. Robertson · DirectorSince 2023
-
Sarah B. Kavanagh · DirectorSince 2023
-
Schutter Richard U. De · DirectorSince 2023
-
Steven H. Collis · DirectorSince 2026
-
Thomas Appio · DirectorSince 2026
-
Thomas W. Ross Sr. · DirectorSince 2023
Chief executives
Outstanding · grade A
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 81
10.6% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.7%
-
98.7%
-
98.7%
-
98.7%
-
98.7%
-
98.7%
-
98.7%
-
98.7%
-
98.7%
Board connections
15 of this board's directors also sit on 16 other boards. 7 are in the same sector.
-
Bausch Health Companies Inc. Same sectorvia Brett Icahn, John Paulson, Russel C. Robertson, Sarah B. Kavanagh, Schutter Richard U. De, Thomas Appio and Thomas W. Ross Sr.
- via Barbara Trebbi, John Paulson and Robert J. Chersi
- via Brett Icahn and Gaoxiang Hu
- via Brett Icahn and Gaoxiang Hu
- via Brett Icahn and Gaoxiang Hu
-
ARS Pharmaceuticals Inc. Same sectorvia Brent L. Saunders
- via Laurence E. Paul
- via Brett Icahn
-
Celularity Inc. Same sectorvia Eschenbach Andrew C. Von
-
Cencora Inc. Same sectorvia Steven H. Collis
- via Steven H. Collis
- via Brett Icahn
- via Brett Icahn
-
SkinHealth Systems Inc. Same sectorvia Brent L. Saunders
-
TriSalus Life Sciences Inc. Same sectorvia Eschenbach Andrew C. Von
-
iRhythm Holdings Inc. Same sectorvia Karen Ling
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,224,173
- 9 purchases by 9 insiders
- Sold, last 12 months
- $3,488,437
- 4 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Eduardo Alfonso Director | Grant or award | +1,125 | $20.40 | $22,950 |
| Oct 29, 2026 | John Paulson Director | Grant or award | +1,125 | $20.40 | $22,950 |
| Oct 29, 2026 | Russel C. Robertson Director | Grant or award | +1,256 | $20.40 | $25,622 |
| Oct 29, 2026 | Munsch Frederick Officer (SVP, Controller and CAO) | Option exercise | +24,103 | $17.96 | $432,890 |
| Oct 29, 2026 | Munsch Frederick Officer (SVP, Controller and CAO) | Option exercise | +87,912 | $18.00 | $1,582,416 |
| Oct 29, 2026 | Munsch Frederick Officer (SVP, Controller and CAO) | Open-market sale | −112,015 | $20.48 | $2,294,067 |
| Aug 12, 2026 | Robert J. Chersi Director | Grant or award | +11,776 | — | — |
| Aug 12, 2026 | Laurence E. Paul Director | Grant or award | +11,776 | — | — |
| Aug 12, 2026 | Barbara Trebbi Director | Grant or award | +11,776 | — | — |
| Aug 10, 2026 | Munsch Frederick Officer (SVP, Controller and CAO) | Open-market sale | −52,900 | $16.78 | $887,662 |
| Aug 7, 2026 | Eschenbach Andrew C. Von Director | Open-market sale | −6,059 | $16.58 | $100,458 |
| Aug 6, 2026 | Eschenbach Andrew C. Von Director | Open-market sale | −12,500 | $16.50 | $206,250 |
| Aug 5, 2026 | Bailey A Robert D Officer (EVP & Chief Legal Officer) | Grant or award | +33,557 | — | — |
| Aug 5, 2026 | Brent L. Saunders Director, Officer (Chairman of the Board and CEO) | Shares withheld for tax | −4,231 | $16.76 | $70,912 |
| Aug 5, 2026 | Bonnefoy Luc Officer (President, Surgical) | Grant or award | +16,778 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Bausch + Lomb Corporation
Who is the CEO of Bausch + Lomb Corporation?
Brent L. Saunders has been Bausch + Lomb Corporation's CEO and Chair since March 2023.
How many directors are on Bausch + Lomb Corporation's board?
Bausch + Lomb Corporation's board has 17 directors: Barbara Trebbi, Brent L. Saunders, Brett Icahn, Eduardo Alfonso, Eschenbach Andrew C. Von, Gaoxiang Hu, John Paulson, Karen Ling, Laurence E. Paul, Nathalie D. Bernier and 7 others.
Are Bausch + Lomb Corporation insiders buying or selling shares?
Over the last 12 months, Bausch + Lomb Corporation insiders bought $1.2 million of shares in 9 purchases and sold $3.5 million of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="bausch-lomb-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.